The soluble forms of the receptors have been reported to act as physiological attenuators of TNF-α activity [26], where the shedding of TNF-Rs leads to diminished surface receptors and this process has been proposed to reduce the clinical activity resulting from TNF-α in rheumatoid arthritis [27]. The gene discussed is TNF; the disease is rheumatoid arthritis.